Targeted Combination Shows Promise in Metastatic Kidney Cancer

(MedPage Today) -- LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug combination, which held disease progression at bay for 2 years, a small multicenter clinical study showed...